Browse studies

Find your next paid study

30 recruiting studies matching your filters

Phase I Trial of Ruxolitinib Plus Fostamatinib for the Treatment of Steroid Refractory Chronic Graft Versus Host Disease

This is an open-label phase I study of fostamatinib in combination with ruxolitinib for the treatment of chronic GvHD with a suboptimal response to corticoster…

Chronic Graft Versus Host Disease

Estimated

~$10 – $7,500

Stefanie Sarantopoulos, MD, PhD.NCT06233110

Phase 2

Phase II Study of Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant in T-Cell Lymphoma

This phase II trial tests how well ruxolitinib as a maintenance medication works to prevent relapse and graft-versus-host disease (GVHD) for patients who have …

T-cell LymphomaGraft Versus Host DiseaseLymphoma, T-Cell+5 more

Estimated

~$10 – $7,500

Jonathan BrammerNCT07356245

Phase 2

A Phase II Study of Ibrutinib as Prophylaxis for Chronic Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)

This phase II trial tests how well ibrutinib works in preventing chronic graft-versus-host disease (GVHD) in patients undergoing donor (allogeneic) hematopoiet…

Chronic Graft Versus Host DiseaseHematopoietic and Lymphatic System Neoplasm

Estimated

~$10 – $6,250

Mayo ClinicNCT06271616

Registry and Biobank of Patients With a History of Cancer Therapy

The purpose of this study is to collect data on patients seen at University of Maryland after undergoing cancer therapy. Previous medications, ocular history, …

Graft Versus Host Disease in EyeOcular ComplicationsInflammatory Dry Eye Disease

Estimated

~$10 – $750

University of Maryland, BaltimoreNCT06874283

Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients. A Multi-center, Observational Trial.

The study will have two separate patient cohorts: Cohort 1 will include patients with newly diagnosed chronic graft versus host disease (GVHD), whereas cohort …

Chronic Lung DiseaseHematopoietic Cell TransplantationGraft Versus Host Disease

Estimated

~$10 – $750

University of Michigan Rogel Cancer CenterNCT05866302

Natural History of Chronic Graft-versus-Host Disease in the Oral Cavity of Patients Following Allogeneic Hematopoietic Stem Cell Transplant and Including Healthy Controls

Background: This study follows people who have had, or will soon have, a transplant using stem cells from another person. This is known as an allogeneic hemat…

Graft Versus Host Disease

Estimated

~$10 – $675

National Institute of Dental and Craniofacial Research (NIDCR)NCT03602599